What IBD patients need to know about COVID-19
As new COVID-19 (coronavirus) variants continue to effect people in the United States, we understand you may have concerns about how it impacts patients with Crohn’s disease or ulcerative colitis. The Foundation is here to help you make sense of the available information and understand the precautions recommended by the Centers for Disease Controls and Prevention (CDC).
COVID-19 & IBD
There are many types of coronaviruses that can affect both humans and animals. In humans, some of these viruses are common and cause mild symptoms, like the common cold, while other types of human strains can be more severe. At the end of 2019, a new coronavirus affecting humans, named SARS-CoV-2, was identified. SARS-CoV-2 causes COVID-19. New variants and subvariants of COVID-19 continue to appear in our country, causing illness. Reported COVID-19 cases have ranged from mild to severe, including death.
There are several COVID-19 vaccinations approved for use by the U.S. Food & Drug Administration (FDA). Here are some frequently asked questions about the available vaccines and what people with IBD need to know.
If you test positive for COVID-19, there are several treatments available that you may be eligible to receive depending on the severity of your illness and your risk of severe disease.
The content on this page was reviewed and created the Crohn’s & Colitis Foundation’s COVID-19 Taskforce, consisting of members of the Foundation's National Scientific Advisory Committee. This content was last updated on 12/14/22.
This resource is generously supported, in part, by: